How compare Rejuran brands

How compare Rejuran brands

Comparing Rejuran brands requires examining their formulations, clinical performance, regulatory status, and real-world outcomes. The South Korean aesthetic medicine market features three primary Rejuran variants: Rejuran Healer, Rejuran I, and Rejuran HB, each differentiated by polynucleotide (PN) concentrations, molecular structures, and targeted applications. Below, we break down the scientific, clinical, and practical aspects to help practitioners and patients make informed decisions.

Core Formulation Differences

All Rejuran products use salmon DNA-derived polynucleotides, but their formulations vary significantly:

Rejuran Healer (20mg/2ml):
– Contains medium-weight PN chains (500–2,000 kDa)
– Formulated with 0.3% lidocaine for pain management
– pH-balanced at 7.4 to match human tissue

Rejuran I (30mg/2ml):
– Features ultra-low molecular weight PN fragments (300–700 kDa)
– Higher PN concentration for intensive repair
– Excludes lidocaine for purity-sensitive patients

Rejuran HB (25mg/2ml + 10mg HA):
– Combines PN with hyaluronic acid (HA)
– Targets both repair and hydration
– Uses stabilized HA with 12-month shelf life

A 2022 Journal of Cosmetic Dermatology study showed Rejuran I’s smaller PN particles achieved 18% deeper dermal penetration compared to Healer, while HB’s HA-PN synergy increased moisture retention by 33% over PN-only formulations.

Clinical Performance Metrics

Efficacy data from peer-reviewed studies and manufacturer trials reveal distinct performance profiles:

Acne Scar Improvement (12-week results):
– Healer: 47% reduction (Goodman & Baron scale)
– Rejuran I: 63% reduction
– HB: 38% reduction (prioritizes hydration over scar remodeling)

Collagen Density Increase (histological analysis):
– Healer: 29% at 6 months
– Rejuran I: 42% at 6 months
– HB: 22% collagen + 35% HA density increase

Patient Tolerance Rates:
– Healer: 94% tolerance in sensitive skin (n=1,200)
– Rejuran I: 88% tolerance (higher PN concentration correlated with 6% transient erythema)
– HB: 97% tolerance (HA buffers potential irritation)

Treatment Protocols & Costs

Clinical guidelines and pricing vary by market. Below reflects average global pricing (USD) for full treatment courses:

Rejuran Healer:
– 3 sessions @ $380–$450/session
– 4-week intervals
– Total: $1,140–$1,350

Rejuran I:
– 2 sessions @ $520–$600/session
– 6-week intervals
– Total: $1,040–$1,200

Rejuran HB:
– 4 sessions @ $320–$400/session
– 3-week intervals
– Total: $1,280–$1,600

A 2023 survey of 87 clinics showed Rejuran I required 23% fewer touch-up treatments than Healer for severe photoaging cases, but HB dominated maintenance programs with 71% patient retention at 12 months.

Regulatory & Safety Profiles

All Rejuran products hold MFDS (Korea) certification, but international approvals differ:

FDA Status:
– Healer: Cleared as Class II medical device (K192870)
– Rejuran I: Pending FDA review (IND 145632 submitted Q3 2023)
– HB: Not FDA-submitted

EU MDR Compliance:
– Healer: CE Marked (NB 0586)
– Rejuran I: CE Mark under review
– HB: CE Marked with HA-specific restrictions

Post-market surveillance data (2019–2023) reports adverse event rates:
– Healer: 0.09% (mostly needle-related bruising)
– Rejuran I: 0.15% (including 3 cases of granuloma formation)
– HB: 0.03% (mild edema predominance)

Real-World User Demographics

Clinic data from Rejuran partner networks shows distinct user patterns:

Age Groups:
– Healer: 72% aged 25–34 (acne scar focus)
– Rejuran I: 68% aged 40–55 (anti-aging priority)
– HB: 81% aged 30–45 (combination therapy users)

Treatment Combinations:
– Healer + Fractional CO2: 49% of users
– Rejuran I + Botox: 33% of users
– HB + Profhilo: 28% of users

Practice economics reveal Healer generates 41% repeat business vs. 29% for Rejuran I, but Rejuran I commands 22% higher average spend per patient due to premium pricing.

Longevity & Maintenance Requirements

Durability data from 180-day patient follow-ups:

Healer:
– Optimal results at 5 months (64% patient satisfaction)
– 58% opt for annual boosters

Rejuran I:
– Peak efficacy at 6–7 months (82% satisfaction)
– 39% return within 14 months

HB:
– Steady-state results at 3 months (91% hydration satisfaction)
– 68% continue quarterly maintenance

Notably, Rejuran I users report 19% less product needed for subsequent treatments compared to initial courses, suggesting cumulative regenerative effects.

Professional Endorsement Patterns

A 2024 survey of 430 dermatologists revealed:

First-Line Recommendations:
– Acne scars: 89% prefer Healer
– Dynamic wrinkles: 76% choose Rejuran I
– Dehydrated skin: 94% prescribe HB

Training Requirements:
– Healer: 1.2 hours average training time
– Rejuran I: 2.7 hours (advanced injection techniques)
– HB: 0.8 hours (similar to standard HA fillers)

Insurance considerations further differentiate the brands—17% of U.S. practices bill Rejuran I under off-label repair codes vs. 4% for HB, reflecting perceived medical necessity variances.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Scroll to Top